Annual EBITDA:
-$263.94M-$81.34M(-44.55%)Summary
- As of today, RYTM annual EBITDA is -$263.94 million, with the most recent change of -$81.34 million (-44.55%) on December 31, 2024.
- During the last 3 years, RYTM annual EBITDA has fallen by -$95.04 million (-56.27%).
- RYTM annual EBITDA is now -3964.99% below its all-time high of -$6.49 million, reached on December 1, 2014.
Performance
RYTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$44.92M+$1.70M(+3.66%)Summary
- As of today, RYTM quarterly EBITDA is -$44.92 million, with the most recent change of +$1.70 million (+3.66%) on June 30, 2025.
- Over the past year, RYTM quarterly EBITDA has dropped by -$4.83 million (-12.05%).
- RYTM quarterly EBITDA is now -14530.94% below its all-time high of -$307.00 thousand, reached on September 1, 2014.
Performance
RYTM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$175.91M-$4.83M(-2.82%)Summary
- As of today, RYTM TTM EBITDA is -$175.91 million, with the most recent change of -$4.83 million (-2.82%) on June 30, 2025.
- Over the past year, RYTM TTM EBITDA has increased by +$87.92 million (+33.32%).
- RYTM TTM EBITDA is now -4431.43% below its all-time high of -$3.88 million, reached on September 1, 2015.
Performance
RYTM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RYTM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -44.5% | -12.1% | +33.3% |
| 3Y3 Years | -56.3% | -0.4% | +8.3% |
| 5Y5 Years | -81.8% | -41.5% | -30.3% |
RYTM EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -56.3% | at low | -15.5% | +67.8% | -2.8% | +34.8% |
| 5Y | 5-Year | -94.2% | at low | -31.7% | +67.8% | -30.4% | +34.8% |
| All-Time | All-Time | -3965.0% | at low | >-9999.0% | +67.8% | -4431.4% | +34.8% |
RYTM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.92M(+3.7%) | -$175.91M(-2.8%) |
| Mar 2025 | - | -$46.62M(-14.1%) | -$171.08M(+35.2%) |
| Dec 2024 | -$263.94M(-44.5%) | -$40.87M(+6.0%) | -$263.94M(-0.0%) |
| Sep 2024 | - | -$43.50M(-8.5%) | -$263.92M(-0.0%) |
| Jun 2024 | - | -$40.09M(+71.3%) | -$263.83M(+2.2%) |
| Mar 2024 | - | -$139.48M(-241.5%) | -$269.80M(-48.0%) |
| Dec 2023 | -$182.60M(-2.7%) | -$40.85M(+5.9%) | -$182.30M(+0.5%) |
| Sep 2023 | - | -$43.41M(+5.8%) | -$183.18M(-2.5%) |
| Jun 2023 | - | -$46.06M(+11.4%) | -$178.67M(-0.8%) |
| Mar 2023 | - | -$51.98M(-24.6%) | -$177.33M(+0.2%) |
| Dec 2022 | -$177.75M(-5.2%) | -$41.73M(-7.3%) | -$177.75M(+4.8%) |
| Sep 2022 | - | -$38.89M(+13.0%) | -$186.69M(+2.6%) |
| Jun 2022 | - | -$44.72M(+14.7%) | -$191.72M(-2.5%) |
| Mar 2022 | - | -$52.41M(-3.4%) | -$187.11M(-10.8%) |
| Dec 2021 | -$168.90M(-24.3%) | -$50.66M(-15.3%) | -$168.90M(-10.3%) |
| Sep 2021 | - | -$43.92M(-9.5%) | -$153.13M(-6.8%) |
| Jun 2021 | - | -$40.12M(-17.3%) | -$143.32M(-6.2%) |
| Mar 2021 | - | -$34.20M(+2.0%) | -$134.95M(+0.7%) |
| Dec 2020 | -$135.88M(+6.4%) | -$34.90M(-2.3%) | -$135.88M(-0.6%) |
| Sep 2020 | - | -$34.11M(-7.5%) | -$135.02M(+2.0%) |
| Jun 2020 | - | -$31.75M(+9.6%) | -$137.83M(+8.1%) |
| Mar 2020 | - | -$35.13M(-3.2%) | -$150.02M(-3.3%) |
| Dec 2019 | -$145.17M | -$34.03M(+7.8%) | -$145.17M(-5.1%) |
| Sep 2019 | - | -$36.92M(+16.0%) | -$138.07M(-14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$43.94M(-45.1%) | -$120.29M(-31.7%) |
| Mar 2019 | - | -$30.27M(-12.4%) | -$91.31M(-17.1%) |
| Dec 2018 | -$77.97M(-142.2%) | -$26.94M(-40.8%) | -$77.97M(-25.8%) |
| Sep 2018 | - | -$19.14M(-27.9%) | -$61.96M(-21.4%) |
| Jun 2018 | - | -$14.96M(+11.7%) | -$51.05M(-19.3%) |
| Mar 2018 | - | -$16.94M(-55.1%) | -$42.79M(-32.9%) |
| Dec 2017 | -$32.19M(-25.0%) | -$10.92M(-32.7%) | -$32.19M(-51.4%) |
| Sep 2017 | - | -$8.23M(-22.9%) | -$21.27M(-63.1%) |
| Jun 2017 | - | -$6.70M(-5.8%) | -$13.04M(-8.3%) |
| Mar 2017 | - | -$6.33M(-11.0%) | -$12.04M(+39.4%) |
| Dec 2016 | -$25.76M(-143.6%) | - | - |
| Jun 2016 | - | -$5.71M(-5.8%) | -$19.86M(-40.3%) |
| Mar 2016 | - | -$5.39M(+4.5%) | -$14.15M(-61.5%) |
| Dec 2015 | -$10.57M(-62.8%) | - | - |
| Dec 2015 | - | -$5.64M(-80.9%) | -$8.76M(-125.7%) |
| Sep 2015 | - | -$3.12M(-309.4%) | -$3.88M(+51.7%) |
| Dec 2014 | -$6.49M(+69.7%) | -$762.00K(-148.2%) | -$8.03M(-10.5%) |
| Sep 2014 | - | -$307.00K(+91.1%) | -$7.27M(-4.4%) |
| Jun 2014 | - | -$3.43M(+2.8%) | -$6.96M(+29.5%) |
| Mar 2014 | - | -$3.53M(+44.4%) | -$9.88M(+8.7%) |
| Dec 2013 | -$21.43M(-18.2%) | - | - |
| Jun 2013 | - | -$6.35M(-41.7%) | -$10.82M(-141.7%) |
| Mar 2013 | - | -$4.48M | -$4.48M |
| Dec 2012 | -$18.12M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of RYTM is -$263.94M
What is the all-time high annual EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual EBITDA is -$6.49M
What is Rhythm Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, RYTM annual EBITDA has changed by -$81.34M (-44.55%)
What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of RYTM is -$44.92M
What is the all-time high quarterly EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$307.00K
What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, RYTM quarterly EBITDA has changed by -$4.83M (-12.05%)
What is Rhythm Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of RYTM is -$175.91M
What is the all-time high TTM EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM EBITDA is -$3.88M
What is Rhythm Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, RYTM TTM EBITDA has changed by +$87.92M (+33.32%)